Navigation Links
Wireless Networking for S/5 Compact Monitor and Datex-Ohmeda S/5 FM

ProductsWireless Networking for S/5 Compact Monitor and Datex-Ohmeda S/5 FM
Company Datex-Ohmeda, Inc.
Item Wireless Networking for S/5 Compact Monitor and Datex-Ohmeda S/5 FM
Features 
  • Seamless centralized monitoring within a care unit
  • Monitoring of any bed in seconds
  • Monitoring and data continuity during demanding point-to-point transport
  • Includes all wired networking features
  • Network printing
  • Remote alarm management
  • Monitor-to-monitor viewing
  • Receiving alarms from other beds
  • Past patient cases can be loaded to wireless monitor
  • Trend data transfer for data continuity
  • Anesthesia Record keeping
  • Distributed viewing on information in other Centrals, ViewStations and WebViewers
  • Easily upgradable to any existing S/5 Compact Monitor and S/5 FM
  • State of the art Symbol Technologies Inc. DSSS technology
  • Operates on licence free ISM (Industrial, Scientific and Medical) 2.45 GHz radio frequency band
  • 802.11b compliant
  • Wi-Fi certification
  • 11 Mbps Communication speed
  • Automatic roaming between Access Points without signal dropouts
  • The same Access Point can be used for all functions, like bed-to-bed viewing, central viewing and network printing.
    • Description Continuous centralized monitoring with wireless connectivity

    The wireless functionality is an optional feature for the S/5 monitoring system that makes it possible to connect S/5 Compact Monitor and S/5 FM to the S/5 Central Station via Wireless LAN technology.

    Wireless operation is a flexible way of providing continuous centralized surveillance within the care unit. It allows easy moving of the patient monitor to a new location without interrupting connection to the S/5 Central Station. It can also be used for transportation to have uninterrupted data continuity through the patient case.
    Info Datex-Ohmeda, Inc.
    Customer Service: (800) 345-2700
    Web site: http://www.us.datex-ohmeda.com/index.asp

    Related medicine products :

    1. Flowmaster Wireless Uroflowmeter
    2. TRITON™ Wireless Urodynamics Systems with optional video
    3. Solenette™ Wireless Urodynamics Systems
    4. Delphis™ Wireless Urodynamics System
    5. Wireless Propaq® CS
    6. The LifeSync Wireless ECG System
    7. Celaris Wireless Alarm/Monitoring System
    8. FlashLink® Wireless System
    9. Compact Ultrasonic Phacoemulsification System
    10. Oculus Easyfield Compact Perimeter
    11. Compact 30C CO2 Lasers
    2-ply material consisting of polyethylene film inner layer and non-woven outer layers.
    Cocoon Disposable Patient Warming Blankets are specially designed to prevent hypothermia and maintain normothermia in your patients. The soft warm coloured material is strong and resists tearing and
    The cardiac blanket is pre-positioned at the waist during prep, unrolled upon closure of the saphenous vein graft incision, and inflated post-bypass.
    The full access underbody blanket is positioned on the procedure table before the patient arrives to the room.
    Medicine Products:
    (Date:7/25/2008)...s of Marketing Exclusivity Begins -, CORONA, Cali...aceuticals, Inc. (NYSE: WPI ), a leading specialt... subsidiary has commenced commercial,shipment of i... in the 40mg,strength from its Davie, Florida manu..., Watson has 180 days of marketing exclusivity for...
    (Date:7/25/2008)...ion Executive, Robert J. Reilly, Joins Aethon Team...,( http://www.aethon.com ), the leading developer ...tics, today announced that Robert J. Reilly has,jo... Financial Officer., Reilly, who was most recentl...orporation,s Specialty Pharmacy Division, brings m...
    (Date:7/25/2008)...ewswire/ -- The Elekta Family of Companies will,sh...ions at the 2008,American Association of Physicist... how the joint forces of Elekta, IMPAC and CMS are...g and delivery solutions that,streamline the treat...ients, as well as enhance clinician efficiency., ...
    (Date:7/25/2008)...y 25 /PRNewswire/ -- AutoGenomics, Inc. today,anno...n Form S-1 with the,Securities and Exchange Commis...ing of shares of its common stock. The number of s...are expected to be offered by,AutoGenomics, Inc., ... been,determined., J.P. Morgan Securities Inc. is...
    Breaking Medicine News(10 mins):Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Aethon, Inc. Names New Chief Financial Officer 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2
    ...netary Fund (IMF) said that there would be a signi...had not set aside a plan of action against the avi...watchdog. It said that a pandemic would trigger sh...s commodities, tourism and trade would recede and ...
    ...ntists from Princeton University says that running...of exercising. The reserachers led by Elizabeth Go...science that running alone does not seem to genera...after running or exercising in pairs or in groups....
    ...ection for a zone in Torun, in northern Poland on ...ad swan was found. Polish vets confirmed the prese...he swan was found near the German border but the v...he bird had the potent strain that could infect hu...
    ...mbia and Maryland may stand to lose heavily in fed...cal health departments to record identities of peo... two jurisdictions figure among many in the countr...s using codes and not names. The Centers for Disea...
    Other Medicine News:
    (Date:7/24/2008)...July 24 /PRNewswire-USNewswire/ -- Headlines claim...he whole story. The small scale,preliminary study...n,Reproduction, is based on recollected intake of ...oods. "This study is confounded by many,issues, th...t deal of,caution," warned Dr. Tammy Hedlund, a re...
    (Date:7/24/2008)...OLIS, France, July 24 /- Ni... top-line results from the 52-week,open label safe...letion of,the 301 phase 3 study for naproxcinod. T...and efficacy was maintained for the one-year durat...bal assessment scale. In,addition, the results sho...
    (Date:7/23/2008)...July 23 /PRNewswire-USNewswire/ -- The following w...hairman Conyers, Ranking Member Smith, and Members...o testify today., Since I appeared before this Co...better acquainted with the talented and dedicated ...he work they do, and I have come to,appreciate tha...
    (Date:7/23/2008)...y 23 /- Dendreon Corporatio... the Independent Data,Monitoring Committee (IDMC) ...overall survival relating to the Company,s Phase 3... Treatment, also known as D9902B) clinical trial,o...any,s investigational,active cellular immunotherap...
    Breaking Medicine Technology:Soyfoods Do Not Impact Sperm Count 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 2NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 3NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension 4Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Study finds circumcision safe in both HIV infected and HIV uninfected men 20907 1Study finds circumcision safe in both HIV infected and HIV uninfected men 20907 2Study finds circumcision safe in both HIV infected and HIV uninfected men 20907 3Chinese Officials Cancel Dog Cull in Earthquake Zone 20905 1Chinese Officials Cancel Dog Cull in Earthquake Zone 20905 2Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma 2298 1Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R788 in Lymphoma 2298 2Oticon Tapes Out Innovative Hearing Aid DSP Using Synopsys IC Compiler 20903 1Oticon Tapes Out Innovative Hearing Aid DSP Using Synopsys IC Compiler 20903 2Oticon Tapes Out Innovative Hearing Aid DSP Using Synopsys IC Compiler 20903 3
    ... Profile and Excellent,Pharmacokinetic Properties ...RNewswire/ --,CeNeRx BioPharma, Inc., a clinical s...tive treatments for diseases of the central,nervou...Phase I,clinical trial of Tyrima(TM), its lead can.... In this study, Tyrima was safe and well,tolerate...
    ...7 /PRNewswire-FirstCall/ -- CV,Therapeutics, Inc. ...ogy (JACC) has published data from the Ranolazine ... long-term therapy with,Ranexa(R) (ranolazine exte...d in patients with chronic stable angina who compl...led in the ROLE,program. , These data also suggest...
    Other Medicine Technology:CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 2CeNeRx BioPharma Announces Positive Phase I Results in First Human,Trial of Third Generation RIMA Antidepressant 3JACC Publishes Long-Term Safety and Tolerability Data from,Ranolazine Open Label Experience (ROLE) Program 2JACC Publishes Long-Term Safety and Tolerability Data from,Ranolazine Open Label Experience (ROLE) Program 3JACC Publishes Long-Term Safety and Tolerability Data from,Ranolazine Open Label Experience (ROLE) Program 4